Alex Fässler
Direttore operativo presso Targimmune Therapeutics AG
Patrimonio netto: 3 M $ in data 30/04/2024
Profilo
Alex Fässler is currently the Head of Operations at Targimmune Therapeutics AG.
Previously, he worked as the Chief Operating Officer at Bachem Holding AG and as the Head of Production & Site Manager at Bachem AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
31/12/2022 | 33 580 ( 0.04% ) | 3 M $ | 30/04/2024 |
Posizioni attive di Alex Fässler
Società | Posizione | Inizio |
---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Direttore operativo | - |
Precedenti posizioni note di Alex Fässler
Società | Posizione | Fine |
---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | - |
BACHEM HOLDING AG | Direttore operativo | - |
Formazione di Alex Fässler
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Aziende private | 2 |
---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Alex Fässler